Home LiteratureArticle Details
PMID: 19116756 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't

Tumor-associated macrophage correlated with angiogenesis and progression of mucoepidermoid carcinoma of salivary glands.

Annals of surgical oncology ·Vol. 16 ·No. 3 ·2009-03-00 ·Pages 751-60

Shieh YS, Hung YJ, Hsieh CB, Chen JS, Chou KC, Liu SY

Abstract

There is considerable controversy about whether tumor-associated macrophages (TAMs) promote or inhibit tumor progression. The present study examined the clinicopathologic significance of TAMs and their association with tumor angiogenesis, cell proliferation, and apoptosis in mucoepidermoid carcinoma (MEC). The potential effect of TAMs on cancer cells was also investigated. CD68, CD34, Ki-67, and vascular endothelial growth factor (VEGF)-A immunohistochemical staining and terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) were applied to samples from 41 MEC patients. The biologic effect of macrophages on MEC cancer cells was examined in a co-culture system. The proliferation index (PI) was 11.7+/-5.9%, and the apoptotic index (AI) was 4.1+/-2.3% in cancer patients. PI was significantly correlated with tumor grade, and the PI/AI ratio was significantly correlated with tumor size and stage. The distributions of intratumoral TAMs and microvessel density (MVD) were heterogeneous. TAM count associated strongly with tumor size, grading, and MEC staging. A greater intratumoral MVD was observed frequently in patients with large, intermediate/high-grade, and advanced-stage tumors. VEGF-A expression correlated significantly with tumor size and stage. MVD count was closely associated with TAM count and VEGF-A expression. Co-cultured cancer cells with macrophages increased migration and invasion ability of cancer cells. Co-cultured endothelial cells with cancer cells elevated VEGF-A expression, proliferation, and migration, and tube formation of endothelial cells. Our data suggest that TAMs play a tumor-promoting role in MEC. The TAM count, intratumoral MVD, and PI/AI ratio are potentially useful markers of progression in patients with MEC.

MeSH Terms
Antigens, CD/metabolism Antigens, Differentiation, Myelomonocytic/metabolism Apoptosis/physiology Biomarkers, Tumor/metabolism Carcinoma, Mucoepidermoid/blood supply,metabolism,pathology Cell Movement/physiology Cell Proliferation Cells, Cultured Coculture Techniques Endothelium, Vascular/cytology,metabolism Female Humans Immunoenzyme Techniques In Situ Nick-End Labeling Ki-67 Antigen/metabolism Macrophages/metabolism,pathology Male Microvessels Neovascularization, Pathologic/diagnosis Salivary Gland Neoplasms/blood supply,metabolism,pathology Vascular Endothelial Growth Factor A/genetics,metabolism
Chemicals
Antigens, CD Antigens, Differentiation, Myelomonocytic Biomarkers, Tumor CD68 antigen, human Ki-67 Antigen VEGFA protein, human Vascular Endothelial Growth Factor A
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Shieh Yi-Shing
School of Dentistry, National Defense Medical Center, Taipei, Taiwan. ndmcyss@nhri.org.tw
Hung Yi-Jen
Hsieh Chung-Bao
Chen Jin-Shuen
Chou Kuo-Chou
Liu Shyun-Yeu
Article Info
Journal
Annals of surgical oncology
Abbr.
Ann Surg Oncol
ISSN
1534-4681
Published
2009-03-00
Epub
2008-00-31
Pages
751-60
Language
English
Region
United States
NLM ID
9420840
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com